Seminars in Arthritis and Rheumatism
Volume 40, Issue 4 , Pages 343-348 , February 2011

Neuromyelitis Optica Spectrum Disorder as an Initial Presentation of Primary Sjögren's Syndrome

  • J. Michelle Kahlenberg, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to J. Michelle Kahlenberg MD, PhD, Division of Rheumatology, University of Michigan Health System, 3918 Taubman Center, 1500 E. Medical Center Drive, SPC 5358, Ann Arbor, MI 48109-5358

References 

  1. Ozgocmen S, Gur A. Treatment of central nervous system involvement associated with primary Sjögren's syndrome. Curr Pharm Des. 2008;14(13):1270–1273
  2. Morgen K, McFarland HF, Pillemer SR. Central nervous system disease in primary Sjögren's syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum. 2004;34(3):623–630
  3. Theodoridou A, Settas L. Demyelination in rheumatic diseases. Postgrad Med J. 2008;84(989):127–132
  4. Sa MJ. Acute transverse myelitis: A practical reappraisal. Autoimmun Rev. 2009;9(2):128–131
  5. Weinshenker BG, Wingerchuk DM. Neuromyelitis optica: Clinical syndrome and the NMO-IgG autoantibody marker. Curr Top Microbiol Immunol. 2008;318:343–356
  6. Dalakas MC. B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic target. Pharmacol Ther. 2006;112(1):57–70
  7. Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT. Losing your nerves? (Maybe it's the antibodies). Nat Rev Immunol. 2009;9(6):449–456
  8. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130(Pt. 5):1194–1205
  9. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008;131(Pt. 11):3072–3080
  10. Mochizuki A, Hayashi A, Hisahara S, Shoji S. Steroid-responsive Devic's variant in Sjögren's syndrome. Neurology. 2000;54(6):1391–1392
  11. Javed A, Balabanov R, Arnason BGW, Kelly TJ, Sweiss NJ, Pytel P, et al. Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis. Mult Scler. 2008;14(6):809–814
  12. Brinar VV, Habek M, Zadro I, Barun B, Ozretic D, Vranjes D. Current concepts in the diagnosis of transverse myelopathies. Clin Neurol Neurosurg. 2008;110(9):919–927
  13. Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, et al. Autoantibodies against aquaporin-4 in patients with neuropsychiatric SLE and primary Sjögren's syndrome. Arthritis Rheum. 2010;62(4):1198–1200
  14. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805–815
  15. Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations. Semin Ophthalmol. 2008;23(3):191–200
  16. Min JH, Kim HJ, Kim BJ, Lee KW, Sunwoo IN, Kim SM, et al. Brain abnormalities in Sjögren's syndrome with recurrent CNS manifestations: Association with neuromyelitis optica. Mult Scler. 2009;15(9):1069–1076
  17. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol. 2008;65(1):78–83
  18. Tristano AG. A case of Sjögren's syndrome with acute transverse myelitis and polyneuropathy in a patient free of sicca symptoms. Clin Rheumatol. 2006;25(1):113–114
  19. Manabe Y, Sasaki C, Warita H, Hayashi T, Shiro Y, Sakai K, et al. Sjögren's syndrome with acute transverse myelopathy as the initial manifestation. J Neurol Sci. 2000;176(2):158–161
  20. Alhomoud IA, Bohlega SA, Alkawi MZ, Alsemari AM, Omer SM, Alsenani FM. Primary Sjögren's syndrome with central nervous system involvement. Saudi Med J. 2009;30(8):1067–1072
  21. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjögren's syndrome: A study of 82 patients. Medicine. 2004;83(5):280–291(Baltimore)
  22. Gresz V, Kwon TH, Hurley PT, Varga G, Zelles T, Nielsen S, et al. Identification and localization of aquaporin water channels in human salivary glands. Am J Physiol Gastrointest Liver Physiol. 2001;281(1):G247–G254
  23. Cikes N, Bosnic D, Sentic M. Non-MS autoimmune demyelination. Clin Neurol Neurosurg. 2008;110(9):905–912
  24. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64(7):1270–1272
  25. Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, et al. Treatment of neuromyelitis optica with mycophenolate mofetil: Retrospective analysis of 24 patients. Arch Neurol. 2009;66(9):1128–1133
  26. Konttinen YT, Kinnunen E, von Bonsdorff M, Lillqvist P, Immonen I, Bergroth V, et al. Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjögren's syndrome. Arthritis Rheum. 1987;30(3):339–344
  27. Alcântara C, Gomes MJ, Ferreira C. Rituximab therapy in primary Sjögren's syndrome. Ann NY Acad Sci. 2009;1173:701–705(Contemporary Challenges in Autoimmunity)
  28. Yamamoto T, Ito S, Hattori T. Acute longitudinal myelitis as the initial manifestation of Sjögren's syndrome. J Neurol Neurosurg Psychiatry. 2006;77(6):780
  29. Quartuccio L, Ferraccioli GF, De Vita S. Transverse myelitis in primary Sjögren's syndrome: Usefulness of low dose oral cyclophosphamide rather than pulse therapy. Scand J Rheumatol. 2006;35(5):409–410
  30. Kim S, Waters P, Vincent A, Kim S, Kim H, Hong Y, et al. Sjögren's syndrome myelopathy: Spinal cord involvement in Sjögren's syndrome might be a manifestation of neuromyelitis optica. Mult Scler. 2009;15(9):1062–1068
  31. Barroso B. Primary Sjögren's syndrome mimicking neuromyelitis optica. Eur J Int Med. 2007;18(6):507
  32. Anantharaju A, Baluch M, Van Thiel DH. Transverse myelitis occurring in association with primary biliary cirrhosis and Sjögren's syndrome. Dig Dis Sci. 2003;48(4):830–833
  33. Arabshahi B, Pollock AN, Sherry DD, Albert DA, Kreiger PA, Pessler F. Devic disease in a child with primary Sjögren's syndrome. J Child Neurol. 2006;21(4):285–286
  34. Hummers LK, Krishnan C, Casciola-Rosen L, Rosen A, Morris S, Mahoney JA, et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology. 2004;62(1):147–149
  35. Wright RA, O'Duffy JD, Rodriguez M. Improvement of myelopathy in Sjögren's syndrome with chlorambucil and prednisone therapy. Neurology. 1999;52(2):386–388
  36. Williams CS, Butler E, Roman GC. Treatment of myelopathy in Sjögren's syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol. 2001;58(5):815–819
  37. Hermisson M, Klein R, Schmidt F, Weller M, Küker W. Myelopathy in primary Sjögren's syndrome: diagnostic and therapeutic aspects. Acta Neurol Scand. 2002;105(6):450–453
  38. Vincent TL, Richardson MP, Mackworth-Young CG, Hawke SH, Venables PJW. Sjögren's syndrome-associated myelopathy: Response to immunosuppressive treatment. Am J Med. 2003;114(2):145–148

 Sources of Support: Division of Rheumatology, Department of Internal Medicine, University of Michigan.

 The author has no conflicts of interest to disclose.

PII: S0049-0172(10)00080-6

doi: 10.1016/j.semarthrit.2010.05.005

Seminars in Arthritis and Rheumatism
Volume 40, Issue 4 , Pages 343-348 , February 2011

Article Tools

* Image Usage & Resolution